Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-Life Results of a Large Single-Center Stud...

por Mikulski, Damian, Robak, Paweł, Ryżewska, Wiktoria, Stańczak, Kamila, Kościelny, Kacper, Góra-Tybor, Joanna, Robak, Tadeusz
Publicado 2022

Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens

por Robak, Paweł, Szemraj, Janusz, Mikulski, Damian, Drozdz, Izabela, Juszczak, Karolina, Jarych, Dariusz, Misiewicz, Małgorzata, Kościelny, Kacper, Fendler, Wojciech, Robak, Tadeusz
Publicado 2021

High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transpla...

por Mikulski, Damian, Nowicki, Mateusz, Dróźdż, Izabela, Misiewicz, Małgorzata, Kościelny, Kacper Piotr, Okoński, Karol, Krawiec, Kinga, Perdas, Ewelina, Wierzbowska, Agnieszka, Fendler, Wojciech
Publicado 2023